Sfoglia per Rivista CANCER BIOLOGY
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients
2011-01-01 Correale, P.; Botta, C.; Basile, A.; Pagliuchi, M.; Licchetta, A.; Martellucci, I.; Bestoso, E.; Apollinari, S.; Addeo, R.; Misso, G.; Romano, O.; Abbruzzese, A.; Lamberti, M.; Luzzi, L.; Gotti, G.; Rotundo, M. S.; Caraglia, M.; Tagliaferri, P.
pRb2/p130 and VEGF expression in endometrial carcinoma in relation to angiogenesis and histopathologic tumor grade
2006-01-01 Sanseverino, F.; Santopietro, R.; Torricelli, M.; D'Andrilli, G.; Russo, G.; Cevenini, G.; Bovicelli, A.; Leoncini, L.; Scambia, G.; Petraglia, F.; Claudio, P. P.; Giordano, A.
Predicting breast cancer outcome: Traditional prognosticators still on center stage
2010-01-01 Mattioli, E.; Giordano, A.; Pentimalli, F.
Prostaglandin E2: at the crossroads between stem cell development, inflammation and cancer
2007-01-01 Logan, C. M.; Giordano, A.; Puca, A.; Cassone, M.
The role of adipose stem cells in inflammatory bowel disease: From biology to novel therapeutic strategies
2016-01-01 De Francesco, Francesco; Romano, Maurizio; Zarantonello, Laura; Ruffolo, Cesare; Neri, Daniele; Bassi, Nicolã; Giordano, Antonio; Zanus, Giacomo; Ferraro, Giuseppe A.; Cillo, Umberto
Role of the retinoblastoma family in gynecological cancer
2003-01-01 Sanseverino, F.; Torricelli, M.; Petraglia, F.; Giordano, A.
Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine.
2009-01-01 Correale, P; Miano, S. T; Remondo, C; Migali, C; Rotundo, M. S; Macrì, P; Tagliaferri, P; Tassone, P; Caraglia, M; Gotti, G; Francini, G.
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients
2013-01-01 Botta, C.; Barbieri, V.; Ciliberto, D.; Rossi, A.; Rocco, D.; Addeo, R.; Staropoli, N.; Pastina, Pierpaolo; Marvaso, G.; Martellucci, Ignazio; Guglielmo, A.; Pirtoli, Luigi; Sperlongano, P.; Gridelli, C.; Caraglia, M.; Tassone, P.; Tagliaferri, P.; Correale, P.
Targeting the checkpoint kinase WEE1: Selective sensitization of cancer cells to DNA-damaging drugs
2010-01-01 Indovina, P.; Giordano, A.
TMPRSS2:ERG gene fusion a new genetic marker for prostate cancer progression
2007-01-01 Macaluso, M.; Giordano, A.
Traditional and new prognosticators in breast cancer. Nottingham index, Mib-1 and estrogen receptor signaling relmain the best predictors of relapse and survival in a series of 289 cases
2010-01-01 Megha, T.; Neri, A.; Malagnino, V.; Caruso, S.; Onorati, M.; Roviello, F.; Tosi, P.
Treatment for glioma recurrence: New hope?
2010-01-01 Esposito, L.; Caligiuri, I.; Giordano, A.
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse
2016-01-01 Nardone, Valerio; Botta, Cirino; Caraglia, Michele; Martino, Elodia Claudia; Ambrosio, MARIA RAFFAELLA; Carfagno, Tommaso; Tini, Paolo; Semeraro, Leonardo; Misso, Gabriella; Grimaldi, Anna; Boccellino, Mariarosaria; Facchini, Gaetano; Berretta, Massimiliano; Vischi, Gianluca; Rocca, BRUNO JIM; Barone, Aurora; Tassone, Pierfrancesco; Tagliaferri, Pierosandro; DEL VECCHIO, MARIA TERESA; Pirtoli, Luigi; Correale, Pierpaolo
Wasting lives: the effects of toxic waste exposure on health. The case of Campania, Southern Italy
2011-01-01 Barba, M.; Mazza, A.; Guerriero, C.; DI MAIO, M.; Romeo, F.; Maranta, P.; Marino, I. R.; Paggi, M. G.; Giordano, A.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients | 1-gen-2011 | Correale, P.; Botta, C.; Basile, A.; Pagliuchi, M.; Licchetta, A.; Martellucci, I.; Bestoso, E.; Apollinari, S.; Addeo, R.; Misso, G.; Romano, O.; Abbruzzese, A.; Lamberti, M.; Luzzi, L.; Gotti, G.; Rotundo, M. S.; Caraglia, M.; Tagliaferri, P. | - | |
| pRb2/p130 and VEGF expression in endometrial carcinoma in relation to angiogenesis and histopathologic tumor grade | 1-gen-2006 | Sanseverino, F.; Santopietro, R.; Torricelli, M.; D'Andrilli, G.; Russo, G.; Cevenini, G.; Bovicelli, A.; Leoncini, L.; Scambia, G.; Petraglia, F.; Claudio, P. P.; Giordano, A. | - | |
| Predicting breast cancer outcome: Traditional prognosticators still on center stage | 1-gen-2010 | Mattioli, E.; Giordano, A.; Pentimalli, F. | - | |
| Prostaglandin E2: at the crossroads between stem cell development, inflammation and cancer | 1-gen-2007 | Logan, C. M.; Giordano, A.; Puca, A.; Cassone, M. | - | |
| The role of adipose stem cells in inflammatory bowel disease: From biology to novel therapeutic strategies | 1-gen-2016 | De Francesco, Francesco; Romano, Maurizio; Zarantonello, Laura; Ruffolo, Cesare; Neri, Daniele; Bassi, Nicolã; Giordano, Antonio; Zanus, Giacomo; Ferraro, Giuseppe A.; Cillo, Umberto | - | |
| Role of the retinoblastoma family in gynecological cancer | 1-gen-2003 | Sanseverino, F.; Torricelli, M.; Petraglia, F.; Giordano, A. | - | |
| Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine. | 1-gen-2009 | Correale, P; Miano, S. T; Remondo, C; Migali, C; Rotundo, M. S; Macrì, P; Tagliaferri, P; Tassone, P; Caraglia, M; Gotti, G; Francini, G. | - | |
| Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients | 1-gen-2013 | Botta, C.; Barbieri, V.; Ciliberto, D.; Rossi, A.; Rocco, D.; Addeo, R.; Staropoli, N.; Pastina, Pierpaolo; Marvaso, G.; Martellucci, Ignazio; Guglielmo, A.; Pirtoli, Luigi; Sperlongano, P.; Gridelli, C.; Caraglia, M.; Tassone, P.; Tagliaferri, P.; Correale, P. | - | |
| Targeting the checkpoint kinase WEE1: Selective sensitization of cancer cells to DNA-damaging drugs | 1-gen-2010 | Indovina, P.; Giordano, A. | - | |
| TMPRSS2:ERG gene fusion a new genetic marker for prostate cancer progression | 1-gen-2007 | Macaluso, M.; Giordano, A. | - | |
| Traditional and new prognosticators in breast cancer. Nottingham index, Mib-1 and estrogen receptor signaling relmain the best predictors of relapse and survival in a series of 289 cases | 1-gen-2010 | Megha, T.; Neri, A.; Malagnino, V.; Caruso, S.; Onorati, M.; Roviello, F.; Tosi, P. | - | |
| Treatment for glioma recurrence: New hope? | 1-gen-2010 | Esposito, L.; Caligiuri, I.; Giordano, A. | - | |
| Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse | 1-gen-2016 | Nardone, Valerio; Botta, Cirino; Caraglia, Michele; Martino, Elodia Claudia; Ambrosio, MARIA RAFFAELLA; Carfagno, Tommaso; Tini, Paolo; Semeraro, Leonardo; Misso, Gabriella; Grimaldi, Anna; Boccellino, Mariarosaria; Facchini, Gaetano; Berretta, Massimiliano; Vischi, Gianluca; Rocca, BRUNO JIM; Barone, Aurora; Tassone, Pierfrancesco; Tagliaferri, Pierosandro; DEL VECCHIO, MARIA TERESA; Pirtoli, Luigi; Correale, Pierpaolo | - | |
| Wasting lives: the effects of toxic waste exposure on health. The case of Campania, Southern Italy | 1-gen-2011 | Barba, M.; Mazza, A.; Guerriero, C.; DI MAIO, M.; Romeo, F.; Maranta, P.; Marino, I. R.; Paggi, M. G.; Giordano, A. | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile